Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

DYRK3

RBC: DYRK3 · Substrate: DYRKtide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Abemaciclib100.00.56
Defactinib87.70.45
Palbociclib58.80.67
Afatinib53.50.71
Sunitinib47.90.52
Avapritinib45.20.64
Ponatinib41.20.53
Gilteritinib40.90.51
Osimertinib39.10.73
Dacomitinib37.40.66
Crizotinib36.50.58
Selpercatinib32.60.64
Neratinib31.70.60
Gefitinib27.10.65
Pacritinib25.10.45

Known variants

No variants catalogued.
Open in new tab